As I mentioned on Wednesday, after I return from my last little summer trip next week, I plan to write at least a couple of posts analyzing the recent decision of the Court of Appeal for England and Wales in Lufthansa Technik AG v. Astronics Advanced Electronic Systems, [2026] EWCA Civ 964, concerning the relationship among disgorgement of infringers’ profits, causation, noninfringing alternatives, and apportionment. Before I go, though, I thought I would note another matter also relating to infringers' profits that was mentioned this morning on the ip fray blog, namely an order entered on August 11 by the UPC’s Munich Local Division in Edwards Lifesciences Corp. v. Meril GmbH. In an earlier proceeding, the defendant Meril was found to have infringed Edwards’ EP No. 3 669 828, relating to a transcatheter heart valve. The remaining questions yet to be decided concern monetary relief for the infringement. The order anticipates a hearing next month concerning, inter alia, the extent to which the defendant may be ordered to “open its books” to the plaintiff, which in turn may depend on resolution of the other two issues. One is whether UPC or national law applies to infringement that occurred prior to the date the UPC entered into force. In March 2025, the Mannheim Local Division concluded that UPC law applied (see discussion on this blog here and here), so it will be interesting to see whether or not the Munich court follows this approach if the parties themselves do not reach agreement on this issue or settle. The other issue concerns whether the court may take into account profits the defendant made on noninfringing products that the defendant offered as a substitute for the infringing products that were taken off the market. From the order:
The judge rapporteur [Dr. Matthias Zigann] explains that, if this case is not settled or goes to the PMAC [Patent Mediation and Arbitration Centre], it will require a decision from the Court of Appeal. This is because, for the first time, the UPC will need to define the details of a claim for damages and the accompanying claims to open the books with regard to non-infringing products. Although there is some national case law, the situation at hand has not, it seems, been decided: the replacement of an infringing product by a non-infringing product during the lifetime of the patent, and the patent owner's claim that the profits with this non-infringing product must be taken into account when calculating damages. . . .
The judge-rapporteur shared his preliminary assessment of the main legal question of whether profits from non-infringing products could be taken into account when calculating damages, and whether they could therefore be subject to an 'open the books' application. He gave an example: A department store advertises an infringing product, 'A'. A customer sees the advertisement and visits the department store to buy the infringing product “A”. However, the product has been taken off the shelves in the meantime due to a court order. The salesperson sells the customer a non-infringing product, "B", instead. In this situation, the profits made from selling product “B” can be attributed to the patent infringement, the patent-infringing offer. In the present case, it may be necessary to take into account the profits made from non-infringing products that replaced the infringing product in open tenders. However, if the link to the sales of the non-infringing products is more tenuous, this might be viewed differently.
This is a very interesting issue. I’m inclined to think that, although there is a causal connection between the profits earned on sales of the noninfringing substitutes and the earlier offer for sale of infringing products, that causal connection should be viewed as too attenuated. (My understanding of German law, should that factor into the mix, is that it doesn’t have a proximate cause doctrine as such, but that German courts employ the concept of haftungsausfüllende Kausalität to cut the causal chain where damages are too remotely connected to the wrongful act.) Under U.S. utility patent law, there is no disgorgement of the infringer’s profits, so I don’t think this precise issue would come up (unless it were somehow relevant to determining a reasonable royalty, which seems a bit of a stretch). According to Rite-Hite Co. v. Kelley Corp., 56 F.3d 1538 (Fed. Cir. 1995) (en banc), however, infringers can be liable for lost profits on sales of noninfringing goods that compete with infringing products—but not for lost profits on sales of noninfringing complementary products that the patent owner ordinarily sells along with the patented article, unless they “function together with the patented component in some manner so as to produce a desired end product or result” and are therefore “analogous to components of a single assembly or be parts of a complete machine, or . . . constitute a functional unit.” I think that logic would exclude the recovery of the infringer’s profits on noninfringing goods, even if U.S. law otherwise permitted disgorgement in utility patent cases. Of course, UPC law or domestic national law within the E.U. could chart a different path.